GB1554022A - Prostaglandins - Google Patents

Prostaglandins

Info

Publication number
GB1554022A
GB1554022A GB25672/76A GB2567276A GB1554022A GB 1554022 A GB1554022 A GB 1554022A GB 25672/76 A GB25672/76 A GB 25672/76A GB 2567276 A GB2567276 A GB 2567276A GB 1554022 A GB1554022 A GB 1554022A
Authority
GB
United Kingdom
Prior art keywords
prostaglandins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB25672/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB1554022A publication Critical patent/GB1554022A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64—Acyl halides
    • C07C57/72—Acyl halides containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
GB25672/76A 1975-07-14 1976-06-21 Prostaglandins Expired GB1554022A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/595,869 US4026909A (en) 1975-07-14 1975-07-14 Cis-13-PGF2.sub.α analogs

Publications (1)

Publication Number Publication Date
GB1554022A true GB1554022A (en) 1979-10-17

Family

ID=24385022

Family Applications (1)

Application Number Title Priority Date Filing Date
GB25672/76A Expired GB1554022A (en) 1975-07-14 1976-06-21 Prostaglandins

Country Status (14)

Country Link
US (24) US4026909A (es)
JP (1) JPS5210243A (es)
AU (1) AU500639B2 (es)
BE (1) BE844105A (es)
CA (1) CA1064483A (es)
CH (1) CH625797A5 (es)
DE (1) DE2630879A1 (es)
FR (1) FR2317915A1 (es)
GB (1) GB1554022A (es)
HU (1) HU177771B (es)
MX (1) MX3343E (es)
NL (1) NL7607728A (es)
SE (1) SE432593B (es)
ZA (1) ZA763765B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237276A (en) * 1974-06-18 1980-12-02 Hoffmann-La Roche Inc. Bicyclic lactone intermediates for 16-substituted prostaglandins
US4190587A (en) * 1973-08-06 1980-02-26 Hoffmann-La Roche Inc. 4-(3-Oxo-4-trifluoromethyl-1-octenyl)-2-oxo-2H-cyclopenta[b]furans
US4183870A (en) * 1974-01-26 1980-01-15 May & Baker Limited Cyclopentane derivatives
US4123456A (en) * 1974-11-07 1978-10-31 American Cyanamid Company Novel 11-hydroxy-9-keto-5,6-cis-13,14-cis-prostadienoic acid derivatives
US4016184A (en) * 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4207227A (en) * 1976-12-03 1980-06-10 Bayer Aktiengesellschaft Stable suspensions of inorganic fillers in organic polyhydroxyl compounds
DE2739620A1 (de) * 1977-09-02 1979-03-08 Bayer Ag Stabile suspensionen anorganischer fuellstoffe in organischen polyhydroxylverbindungen
US4312810A (en) * 1978-11-22 1982-01-26 The Upjohn Company 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-9-deoxy-PGF1 compounds
JPH0382248U (es) * 1989-12-12 1991-08-22
US5262437A (en) * 1990-12-10 1993-11-16 Allergan, Inc. Homo-prostaglandin derivatives as ocular hypotensives
EP0857718B1 (en) 1996-06-10 2002-08-14 Sucampo AG Endothelin antagonist
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
AU2003243272A1 (en) 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
JP2006508986A (ja) 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
US8487147B2 (en) * 2010-03-01 2013-07-16 Syed Tajammul Hussain Nano-catalyst for fast track bio-diesel production from non-edible oils

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959346A (en) * 1969-03-14 1976-05-25 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
JPS503362B1 (es) * 1970-06-10 1975-02-04
DE2317019A1 (de) * 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine
US3816383A (en) * 1972-05-01 1974-06-11 Nat Petro Chem Separation of olefin polymers
US4011262A (en) * 1972-07-13 1977-03-08 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
US4046801A (en) * 1972-07-18 1977-09-06 Syntex (U.S.A.) Inc. 13-Cis prostaglandin derivatives
US3867377A (en) * 1972-07-18 1975-02-18 Syntex Inc Method of making 13-cis prostaglandin derivatives
US3873607A (en) * 1972-07-24 1975-03-25 American Cyanamid Co 3-Oxa(and thia) 11-deoxy PGE
US3933899A (en) * 1972-10-30 1976-01-20 The Upjohn Company PGE2 -oxa-phenylene compounds
US3914282A (en) * 1973-01-16 1975-10-21 Upjohn Co Prostaglandin E{HD 1{B , F{HD 1{B , and A{HD 1 {B analogs
US3932479A (en) * 1973-04-27 1976-01-13 American Cyanamid Company Lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
US3962293A (en) * 1973-07-20 1976-06-08 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin F1
US3932463A (en) * 1974-06-03 1976-01-13 American Cyanamid Company 11-Deoxy-13-dihydro-prostaglandin-9-ketals
US3970685A (en) * 1974-06-05 1976-07-20 Syntex (U.S.A.) Inc. (DL)-13-Substituted sulfinyl-prostaglandin-like compounds

Also Published As

Publication number Publication date
SE432593B (sv) 1984-04-09
US4122284A (en) 1978-10-24
MX3343E (es) 1980-10-01
US4118578A (en) 1978-10-03
US4122283A (en) 1978-10-24
FR2317915A1 (fr) 1977-02-11
US4118579A (en) 1978-10-03
US4088663A (en) 1978-05-09
US4127725A (en) 1978-11-28
US4161606A (en) 1979-07-17
DE2630879A1 (de) 1977-02-03
US4118580A (en) 1978-10-03
FR2317915B1 (es) 1982-10-22
US4085271A (en) 1978-04-18
CA1064483A (en) 1979-10-16
BE844105A (fr) 1977-01-14
US4127726A (en) 1978-11-28
AU500639B2 (en) 1979-05-31
US4026909A (en) 1977-05-31
SE7607875L (sv) 1977-01-15
CH625797A5 (es) 1981-10-15
US4161605A (en) 1979-07-17
US4122101A (en) 1978-10-24
AU1528176A (en) 1978-01-05
US4127724A (en) 1978-11-28
US4122103A (en) 1978-10-24
HU177771B (en) 1981-12-28
US4129582A (en) 1978-12-12
US4122100A (en) 1978-10-24
ZA763765B (en) 1977-05-25
NL7607728A (nl) 1977-01-18
JPS5210243A (en) 1977-01-26
US4127723A (en) 1978-11-28
US4119651A (en) 1978-10-10
US4122102A (en) 1978-10-24
US4163107A (en) 1979-07-31
US4119787A (en) 1978-10-10
US4118581A (en) 1978-10-03
US4120878A (en) 1978-10-17

Similar Documents

Publication Publication Date Title
GB1554022A (en) Prostaglandins
BG27526A4 (en) Herbicid antipoison
GB1554029A (en) Prostaglandins
CS225976A2 (en) Razove ustroji pohanene tlakovym prostredim
JPS51110930A (en) Bishodenshisochi noseizohoho
JPS51101115A (en) Kokozaisoseibutsuno seiho
CS188141B2 (en) Ski-brake
AU501804B2 (en) 11-oza prostaglandins
GB1485352A (en) Prostaglandins
AU1749676A (en) Prostaglandins
NZ179816A (en) Prostaglandins
JPS5192852A (en) Boonseioyobi boshinseinosuguretaseikeiyososeibutsu
JPS5194771A (en) Daiyamondono metaraizuhoho
CS189776A2 (en) Zpusob regenerace paladiovych katalyzatoru
JPS5193633A (en) Inkufunshasochino jikoshindansochi
AU1105976A (en) 5-nitrothiazolylimidazolidine
JPS51100321A (en) Shikibetsuhyojio jusurusupairarushikanno seizohoho
JPS51110731A (en) Chitsusosankabutsuo teigensuruhoho
BG27522A3 (en) Fungicœde compositiow
JPS51128943A (en) Prostaglandins
CH610841A5 (en) Skibob
JPS5185981A (en) Datsuen datsushushoyukasushiryonoseizoho
GB1554027A (en) Prostaglandins
AU2024876A (en) Prostaglandins
NZ181264A (en) Mono-deuterated prostaglandins

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee